• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene.

作者信息

Pica-Mattoccia L, Dias L C, Moroni R, Cioli D

机构信息

Institute of Cell Biology, Rome, Italy.

出版信息

Exp Parasitol. 1993 Dec;77(4):445-9. doi: 10.1006/expr.1993.1104.

DOI:10.1006/expr.1993.1104
PMID:8253157
Abstract

Two drug-resistant strains of Schistosoma mansoni were compared in this study in order to decide whether they are both mutated in the same gene with respect to drug-sensitive schistosomes. One of the two strains was isolated in the laboratory, while the other one originated from a treated uncured patient and was subsequently drug selected in the laboratory. The approach consisted in a genetic complementation test performed essentially by crossing the two strains and assessing resistance in the progeny. Since no reappearance of drug sensitivity was detected in the progeny, it was concluded that the two strains failed to complement and were therefore mutated in the same gene. This finding suggests that a single step of drug activation operates in sensitive schistosomes and is ineffective in resistant worms.

摘要

相似文献

1
Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene.
Exp Parasitol. 1993 Dec;77(4):445-9. doi: 10.1006/expr.1993.1104.
2
Genetic complementation analysis of two independently isolated hycanthone-resistant strains of Schistosoma mansoni.
Mem Inst Oswaldo Cruz. 1992;87 Suppl 4:211-4. doi: 10.1590/s0074-02761992000800032.
3
Schistosoma mansoni: hycanthone/oxamniquine resistance is controlled by a single autosomal recessive gene.曼氏血吸虫:海恩酮/奥沙尼喹抗性由单个常染色体隐性基因控制。
Exp Parasitol. 1992 Dec;75(4):425-32. doi: 10.1016/0014-4894(92)90255-9.
4
Binding of oxamniquine to the DNA of schistosomes.
Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):373-6. doi: 10.1016/0035-9203(89)90508-7.
5
Experimentally produced resistance of Schistosoma mansoni to hycanthone.曼氏血吸虫对海恩酮的实验性诱导抗性
Am J Trop Med Hyg. 1977 Sep;26(5 Pt 1):926-36. doi: 10.4269/ajtmh.1977.26.926.
6
Enzymatic basis for the lack of oxamniquine activity in Schistosoma haematobium infections.埃及血吸虫感染中奥沙尼喹缺乏活性的酶学基础。
Parasitol Res. 1997;83(7):687-9. doi: 10.1007/s004360050320.
7
Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules.
Mol Biochem Parasitol. 1992 Oct;55(1-2):167-75. doi: 10.1016/0166-6851(92)90137-9.
8
Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
Am J Trop Med Hyg. 1985 Jan;34(1):112-8. doi: 10.4269/ajtmh.1985.34.112.
9
[Genetic and molecular aspects of drug resistance in Schistosoma mansoni].
Ann Ist Super Sanita. 1986;22(1):153-5.
10
[A human strain of Schistosoma mansoni resistant to schistosomicides].
Rev Saude Publica. 1978 Mar;12(1):110.

引用本文的文献

1
CRISPR/Cas genome editing, functional genomics, and diagnostics for parasitic helminths.用于寄生蠕虫的CRISPR/Cas基因组编辑、功能基因组学及诊断方法
Int J Parasitol. 2025 May 19. doi: 10.1016/j.ijpara.2025.05.001.
2
Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.奥沙尼喹衍生物克服了吡喹酮治疗血吸虫病的局限性。
PLoS Pathog. 2023 Jul 10;19(7):e1011018. doi: 10.1371/journal.ppat.1011018. eCollection 2023 Jul.
3
A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance.
一个主要基因座赋予肝片形吸虫对三氯苯达唑的耐药性,并表现出显性遗传。
PLoS Pathog. 2023 Jan 26;19(1):e1011081. doi: 10.1371/journal.ppat.1011081. eCollection 2023 Jan.
4
Clustered Regularly Interspaced Short Palindromic Repeats/ CRISPR associated protein 9-mediated editing of Schistosoma mansoni genes: Identifying genes for immunologically potent drug and vaccine development.丛集规律间隔短回文重复序列/ CRISPR 相关蛋白 9 介导的曼氏血吸虫基因编辑:鉴定具有免疫效力的药物和疫苗开发基因。
Rev Soc Bras Med Trop. 2022 Aug 12;55:e0131. doi: 10.1590/0037-8682-0131-2022. eCollection 2022.
5
An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans.一个迭代过程产生了奥沙尼喹衍生物,可杀死感染人类的主要血吸虫物种。
PLoS Negl Trop Dis. 2020 Aug 18;14(8):e0008517. doi: 10.1371/journal.pntd.0008517. eCollection 2020 Aug.
6
Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?奥沙尼喹为何能杀灭曼氏血吸虫而不能杀灭埃及血吸虫和日本血吸虫?
Int J Parasitol Drugs Drug Resist. 2020 Aug;13:8-15. doi: 10.1016/j.ijpddr.2020.04.001. Epub 2020 Apr 10.
7
Transcriptomic analysis of reduced sensitivity to praziquantel in Schistosoma mansoni.曼氏血吸虫对吡喹酮敏感性降低的转录组学分析
Mol Biochem Parasitol. 2019 Mar;228:6-15. doi: 10.1016/j.molbiopara.2018.12.005. Epub 2019 Jan 15.
8
Genetic Crosses and Linkage Mapping in Schistosome Parasites.血吸虫寄生虫的遗传杂交与连锁图谱构建。
Trends Parasitol. 2018 Nov;34(11):982-996. doi: 10.1016/j.pt.2018.08.001. Epub 2018 Aug 24.
9
Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population.在巴西血吸虫种群中,赋予奥沙尼喹抗性的功能丧失突变的独立起源。
Int J Parasitol. 2016 Jun;46(7):417-24. doi: 10.1016/j.ijpara.2016.03.006. Epub 2016 Apr 9.
10
Comparative biochemical analysis of three members of the Schistosoma mansoni TAL family: Differences in ion and drug binding properties.曼氏血吸虫TAL家族三个成员的比较生化分析:离子和药物结合特性的差异
Biochimie. 2015 Jan;108:40-7. doi: 10.1016/j.biochi.2014.10.015. Epub 2014 Nov 5.